Search - tctmd.com

Displaying 241 - 260 of 523

Sort: Relevancy | Date

COVID-19: TCTMD’s Dispatch for November Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 4

November 22, 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

News Conference News AHA 2021

Pandemic Blamed for Loss of BP Control That Has Not Fully Rebounded

November 18, 2021

ESC Releases Guidance on How to Address CVD in COVID-19 Era

News Daily News

ESC Releases Guidance on How to Address CVD in COVID-19 Era

Yael L. Maxwell

November 17, 2021

Canagliflozin Improves Quality of Life in HF Patients

News Conference News AHA 2021

Canagliflozin Improves Quality of Life in HF Patients

Michael O'Riordan

November 16, 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

News Conference News AHA 2021

No Benefit for Icosapent Ethyl, P2Y12 Inhibitors in Separate COVID-19 Trials

November 15, 2021

COVID-19: TCTMD’s Dispatch for November Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 3

November 15, 2021

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

News Conference News AHA 2021

Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown

Yael L. Maxwell

November 14, 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

November 08, 2021

COVID-19: TCTMD’s Dispatch for November Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 2

November 08, 2021

COVID-19: TCTMD’s Dispatch for November Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for November Week 1

November 01, 2021

November 2021 News Roundup

News Opinion CV Team Dispatch

November 2021 News Roundup

November 01, 2021

STEMI and COVID-19 Often a Lethal Combo, Affirms Largest Study Yet

News Daily News

STEMI and COVID-19 Often a Lethal Combo, Affirms Largest Study Yet

October 29, 2021

COVID-19: TCTMD’s Dispatch for October Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 4

October 25, 2021

Higher CV Mortality Among More Socially Vulnerable US Adults

News Daily News

Higher CV Mortality Among More Socially Vulnerable US Adults

Yael L. Maxwell

October 20, 2021

AHA Policy Statement Focuses on Gaps in STEMI Systems of Care

News Daily News

AHA Policy Statement Focuses on Gaps in STEMI Systems of Care

October 18, 2021

ACC Survey Reveals Racial/Ethnic Gaps but Also Job Satisfaction

News Daily News

ACC Survey Reveals Racial/Ethnic Gaps but Also Job Satisfaction

October 18, 2021

COVID-19: TCTMD’s Dispatch for October Week 3

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 3

October 18, 2021

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

News Daily News

USPSTF at Last Takes Tougher Stance on Aspirin in Primary Prevention

October 15, 2021

Restarting In-Person Interventional Meetings: A Delicate but Necessary Juggling Act

News Opinion Off Script

Restarting In-Person Interventional Meetings: A Delicate but Necessary Juggling Act

Juan F. Granada, MD

October 14, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.